Studying Cannabinoid Anticancer Activity: Experiments and Results
Explore the process of studying cannabinoid anticancer activity through in vitro and in vivo experiments, focusing on the effects of cannabinoids on cultured cancer cells and brain tumor-derived cancer initiating cells (GICs). Learn about the use of cannabinoids in combination with other anticancer agents to achieve a higher therapeutic effect, supported by research findings and results obtained in the lab. Witness the potential of cannabinoids in killing cancer cells, leading to the development of promising strategies in cancer treatment.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Performing experiments with cannabinoids 1. Cannabinoid compounds (pure THC and CBD or botanical drug substances with controlled amounts of these agents) are used in our experiments and are provided companies by different Pharmaceutical 2. Cannabinoids are provided in vials containing the cannabinoids as a resin diluted in ethanol. These vials are stored at -20 C. 3. In order to prepare stock solutions of cannabinoids that can be used in in vitro and in vivo experiments, ethanol must be evaporated and the required amount of cannabinoids re-solved in a lipid solvent. During the processing of samples, cannabinoids must be protected from light and exposed to a nitrogen atmosphere as they are photo- sensitive and can get oxidized very easily.
How do we study cannabinoid anticancer activity? 4. One of the strategies that we use to analyze the anticancer activity of cannabinoids is studying the effect of these agents in cultured cancer cells. Israel L pez-Valero s PhD Thesis project is aimed at optimizing the use of cannabinoids as anticancer agents in glioma (Funding kindly provided by Medical Cannabis bike tour is being used to cover the costs of Israel s contract) 6. One of the cell types in which we are analyzing the effect of cannabinoids in combination with other anticancer agents are the so-called brain-tumor derived cancer initiating cells (GICs). These cells are obtained from brain cancer patients and when cultured form cell aggregates, named neuro-spheres). These cells are believed to be responsible for the resistance of brain tumors to current anticancer therapies. 5. Cancer cells are seeded into Flask where we add the drugs concentrations. We cannabinoids with other anti-cancer agents to produce a better/higher therapeutic effect. at different combine frequently
Cannabinoids can kill cancer cells 7. Here we show a representation of the results obtained in experiments performed in the lab with GICs thanks to the support of MC Biketour Fold increase (regarding Glioma Initiating cells initial numer of cells) 30 No treatment 25 THC + CBD (low doses) 20 Anticancer agent (low doses) 15 Cannabinoid + anticancer agent (low doses) 10 5 0 P0 P1 P2 Passages The combination of cannabinoids and other anticancer agents kills Glioma initiating cells in vitro. GICs are dissociated, counted and seeded at low cell density. After 5 days of incubation with cannabinoids and other compounds (P1), neurospheres are dissociated and total cells counted. Next, equal numbers of cells are re-plated at initial density and treated during 5 more days (P2). The figure shows that the combined treatment with cannabinoids and other anticancer agents (green line) eliminates the population of GICs.
How do we study cannabinoid anticancer activity? 7. After confirming in vitro results we try to reproduce these experiments in vivo, treating the animals with the same combination of cannabinoids and other anticancer agents. To this aim, tumors are generated by intracranial injection of GICs. Once the tumors have reached a certain volume animals are treated with different drugs, including cannabinoids and tumor growth and animal survival are analized. Israel L pez Valero and David D vila (a postdoc who is also working in the project) administer cannabinoids orally (using a gavage) to animals in which brain tumorshave been generated.
